Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 220

The DOI matches its Crossref record.

KAPOSI'S SARCOMA IN TRANSPLANT RECIPIENTS

Penn, Israel·1997·Transplantation

Abstract

Although Kaposi described “idiopathic multiple pigmented sarcoma of the skin” in 1872 (1), the disease was a medical curiosity in Europe and the United States until the acquired immune deficiency syndrome (AIDS*) epidemic was recognized in 1981. The annual incidence was 0.021-0.061 per 100,000 people (2). Kaposi's sarcoma (KS) comprised only 0.02-0.07% of all cancers in the United States (3, 4). KS is a tumor, often of multicentric origin, composed of differing proportions of endothelium-lined vascular spaces and spindle-shaped cells (3). In addition, extravasated red blood cells and clusters of inflammatory cells including lymphocytes and plasma cells may be present. The cell of origin is controversial, and KS has been variously classified as a fibrosarcoma, an endotheliosarcoma, and a lymphoma. However, most investigators agree that it is of endothelial origin (5), and lymphatic endothelial cells appear to be the most likely source (6). This fits with clinical observations that lesions often have a striking cutaneous lymphatic distribution, and lymphedema is frequently present (5). KS occurs in several clinical settings, described below Clinical Settings of Kaposi's Sarcoma Classical KS. Classical KS affects elderly men, mostly Jews of Central and Eastern European origin, and persons of Southern European ancestry (4). Typically, lesions appear on the lower extremities and lymph node, and visceral involvement is uncommon. The disease runs an indolent course and seldom causes death. Spontaneous regression of lesions occurs in approximately 2% of patients (3). Usually it is not associated with immune depression apart from the expected immunologic attrition of aging (5). Endemic KS. Endemic KS occurs in the black population of the rain forest area of Africa, where it makes up 3-9% of cancers (3). In some areas, it is 150-200 times more common than in North America (3). It occurs predominantly in males, but of a younger age group (25-40 years) than in classical KS. They develop nodules of the feet and legs which may regress spontaneously. After an interval of months or years, nodules grow rapidly and ulcerate to give rise to florid tumors or woody infiltration of the limbs (7). Regression is usually achieved with chemotherapeutic agents, and patients live for several years before dying from disseminated disease. This variety of KS is not related to infection with human immunodeficiency virus (HIV). Epidemic KS. Epidemic KS occurs in AIDS patients, in whom the risk of its development is approximately 100 times greater than in the general population (8). More than 24,000 cases have been reported in the United States (9), of which 95% occurred in homosexual/bisexual men and only 5% in other groups at risk for AIDS. KS occurs at an average age of 34 years. The neoplasm is usually widespread and often involves the skin, mucous membranes, gastrointestinal tract, lymph nodes, and almost any organ except the brain (9). Most cases have a rapid fulminant course with extensive skin and visceral involvement (9). Spontaneous remissions occur in less than 4% of cases, usually in those with minimal tumor burdens. KS in organ allograft recipients. An epidemiologic study showed that the incidence of KS in renal transplant patients was increased 400- to 500-fold over that seen in a control population of the same ethnic origin (4). This is borne out by the findings of the Cincinnati Transplant Tumor Registry (CTTR). When nonmelanoma skin cancers and in situ carcinomas of the uterine cervix were excluded, KS comprised 5.7% of neoplasms reported to the CTTR (10). Even more surprising, the total number of cases of KS reported to the CTTR exceeded those of each of two tumors that are common in the general population, namely carcinomas of the colon and breast (10). Clinical Features The average age of presentation of KS in 356 allograft recipients reported to the CTTR was 43 years (range, 4.5-67 years) (11-14). The male-to-female ratio was nearly 3:1, whereas it was as high as 17:1 in classical KS (15). The disease was uncommon in pediatric transplant recipients (16), who comprised only 3% of the patients with KS in the CTTR (11-14), in contrast with endemic KS, which frequently involves children. KS was observed mainly in kidney allograft recipients, with a much smaller incidence in recipients of other solid organs (mainly hearts and livers) (11-14, 17, 18), and was rare in bone marrow allograft recipients (19, 20). The majority of patients (92%) tested negative for HIV (14). The average time of appearance of KS was 21 months (range, 1-225.5 months) after transplantation (11-14). The bulk of the tumors (46%) appeared within 1 year after transplantation. Of 279 patients, whose racial or ethnic origins were noted, the majority were of Arabic, black, Italian, Jewish, or Greek ancestry (11-14). Several studies confirm these findings. KS occurred in 1.6% of 820 Italian renal transplant recipients who were followed for more than 6 months

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/00007890-199709150-00001

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 220

Metadata

Authors
Penn, I.
Venue
Transplantation
Published
1997-09
Volume
64
Issue
5
Pages
669-673
ISSN
0041-1337 (ISSN-L)
OpenAlex
W2091197267
Cited by
220
References
0
FWCI
3.44
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: KAPOSI'S SARCOMA IN TRANSPLANT RECIPIENTS. https://app.cochat.ai/papers/10.1097/00007890-199709150-00001
The paper
Penn, I. (1997). KAPOSI'S SARCOMA IN TRANSPLANT RECIPIENTS. Transplantation. https://doi.org/10.1097/00007890-199709150-00001

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.